Correlation Between BioNexus Gene and Innospec

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioNexus Gene and Innospec at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioNexus Gene and Innospec into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioNexus Gene Lab and Innospec, you can compare the effects of market volatilities on BioNexus Gene and Innospec and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNexus Gene with a short position of Innospec. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNexus Gene and Innospec.

Diversification Opportunities for BioNexus Gene and Innospec

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between BioNexus and Innospec is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding BioNexus Gene Lab and Innospec in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innospec and BioNexus Gene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNexus Gene Lab are associated (or correlated) with Innospec. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innospec has no effect on the direction of BioNexus Gene i.e., BioNexus Gene and Innospec go up and down completely randomly.

Pair Corralation between BioNexus Gene and Innospec

Given the investment horizon of 90 days BioNexus Gene Lab is expected to under-perform the Innospec. In addition to that, BioNexus Gene is 3.83 times more volatile than Innospec. It trades about -0.03 of its total potential returns per unit of risk. Innospec is currently generating about 0.08 per unit of volatility. If you would invest  10,877  in Innospec on September 4, 2024 and sell it today you would earn a total of  1,068  from holding Innospec or generate 9.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

BioNexus Gene Lab  vs.  Innospec

 Performance 
       Timeline  
BioNexus Gene Lab 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioNexus Gene Lab has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Innospec 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Innospec are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Innospec may actually be approaching a critical reversion point that can send shares even higher in January 2025.

BioNexus Gene and Innospec Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioNexus Gene and Innospec

The main advantage of trading using opposite BioNexus Gene and Innospec positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNexus Gene position performs unexpectedly, Innospec can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innospec will offset losses from the drop in Innospec's long position.
The idea behind BioNexus Gene Lab and Innospec pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges